General Reasoning, Inc.

SAN FRANCISCO, CA · Founded 2025 · CIK 0002076240 · Biotech

Oral peptide delivery platform and portable bioreactors for programming biology

general.bio →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$11M
1 Form D · Jul 2025
15 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$10,904,992
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2250OpalGenix, Inc.——
2251ProDa BioTech L.L.C.——
2252AUMENTA BIOSCIENCES, INC.——
2253General Reasoning, Inc.—$11M
2254ADDUCTNE LLC——
2255HNB Therapeutics LLC——
2256LightSeed, Inc.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 4 related persons
  • Thomas Grady IIDirector
  • Kip ParkerDirector
  • Ross TaylorDirector · Executive Officer
  • Chengxi WangDirector · Executive Officer

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.